University Hospital, Basel, Switzerland

This study tests whether trained village health workers can safely manage type 2 diabetes in rural Lesotho using eHealth tools. About 252 adults with diabetes will receive either community-based care (including medication) from local workers or standard clinic care. The goal is t…

This early-phase trial tests a new approach for people with advanced melanoma that cannot be removed by surgery or has spread. Doctors take immune cells from the patient's own tumor, grow them in large numbers, and give them back along with a drug called ANV419 to help them survi…

This study tests whether trained village health workers, supported by mobile health technology, can effectively manage high blood pressure in rural Lesotho. About 1,350 adults with either uncontrolled or controlled hypertension will receive community-based care or be referred to …

This study looks at whether a 1-hour blood test can safely and accurately diagnose heart attacks in people with chest pain, compared to the standard 3-hour test. Over 64,000 adults with chest pain and suspected heart attack will be enrolled. The goal is to see if the faster test …

This study tests a new type of PET-MRI scan to find small pituitary tumors causing Cushing's disease. The goal is to see if this non-invasive scan can replace the current standard test, which involves inserting catheters into veins near the brain. About 43 adults with confirmed C…

This study tests whether a 12-session outdoor group training with animals can help children aged 2-4 or 8-12 who have autism or have gone through stressful life events. The training focuses on self-esteem, handling emotions, and social skills. Researchers will measure changes in …

This study follows 120 people with Long COVID to track their health, symptoms, and possible causes like inflammation or immune issues. A smaller group will test a 12-week smartphone app with breathing exercises, relaxation, and tips to manage fatigue. The goal is to learn more ab…

This study uses surveys to collect real-world experiences and treatment preferences from 530 prolactinoma patients and their doctors. The goal is to understand side effects, outcomes, and what matters most to patients. Findings will help design better future clinical trials and i…